查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1561041

微生物鑑定市场规模、份额、成长分析、按产品和服务、按方法、按技术、按地区 - 行业预测，2024-2031 年

Microbial Identification Market Size, Share, Growth Analysis, By Product & Service, By Method, By Technology, By Region - Industry Forecast 2024-2031
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球微生物鑑定市场规模为45亿美元，从2023年的50.6亿美元成长到2031年的128.9亿美元，复合年增长率预计将成长12.40%。

由于感染疾病率的上升以及人们日益认识到微生物鑑定在疾病诊断和治疗中的重要作用，全球微生物鑑定市场正在显着增长。医疗保健、製药、食品和饮料以及环境监测等各领域对快速、准确的识别方法的需求不断增加。自动化系统、分子诊断和基因组学等技术创新大大增强了微生物鑑定过程，从而获得更快、更准确的结果。此外，研究机构、生物技术和製药公司越来越多地使用微生物鑑定正在推动市场发展。新感染疾病的出现以及对抗菌素抗药性日益增长的担忧凸显了有效识别方法和增加该领域投资的必要性。此外，对个人化医疗的关注和对即时检测的需求也有助于市场扩张。然而，先进识别技术的高成本以及熟练专业人员的缺乏给成长带来了挑战。儘管存在这些障碍，持续的研究和开发工作预计将推动全球微生物鑑定市场的发展，创造创新机会，并改善全球患者照护。

目录

介绍

  • 研究目的
  • 定义
  • 市场范围

调查方法

  • 资讯采购
  • 二手资料来源和主要资料来源
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 市场概况展望
  • 供需趋势分析
  • 按细分市场的机会分析

市场动态及展望

  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
  • 波特的分析

主要市场考察

  • 技术分析
  • 价值链分析
  • 市场生态系统
  • 供应链分析
  • 案例研究分析
  • 监管环境
  • 创新矩阵
  • 主要投资分析
  • 关键成功因素
  • 竞争程度

微生物鑑定市场：依产品/服务分类

  • 市场概况
  • 设备和软体
  • 消耗品
    • 面板/ ID卡和介质
    • 套件
    • 其他消耗品
  • 服务

微生物鑑定市场：依方法分类

  • 市场概况
  • 表型分析方法
  • 基于蛋白质体学的方法
  • 基因型法

微生物鑑定市场：依技术分类

  • 市场概况
  • 基于质谱的微生物鑑定
  • 基于PCR的微生物鑑定
  • 基于流式细胞技术的微生物鑑定
  • 基于显微镜的微生物鑑定
  • 其他微生物鑑定技术

微生物鑑定市场：依应用分类

  • 市场概况
  • 诊断用途
    • 人类疾病的诊断
    • 动物疾病诊断
  • 製药应用
  • 食品检验
  • 饮料测试
  • 化妆品和个人保健产品测试
  • 环境应用
  • 其他用途

微生物鑑定市场：依最终用户分类

  • 医院、诊断实验室、血库
  • 製药公司和受託研究机构
  • 食品製造公司
  • 饮料製造公司
  • 其他最终用户

微生物鑑定市场规模：按地区

  • 市场概况
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲 (MEA)
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲地区

竞争格局

  • 前5名企业对比
  • 主要企业市场定位（2023年）
  • 主要市场参与者所采取的策略
  • 近期市集活动
  • 主要企业市场占有率（2023年）

主要企业简介

  • bioMerieux SA（France）
  • Becton, Dickinson and Company（BD）（US）
  • Thermo Fisher Scientific Inc.（US）
  • Danaher Corporation（US）
  • Merck KGaA（Germany）
  • Bruker Corporation（US）
  • Shimadzu Corporation（Japan）
  • Qiagen NV（Netherlands）
  • Avantor, Inc.（US）
  • Accelerate Diagnostics, Inc.（US）
  • Biolog, Inc.（US）
  • Liofilchem Srl（Italy）
  • Trivitron Healthcare（India）
  • Gradian Diagnostics（US）
  • Alifax Srl（Italy）
  • HiMedia Laboratories（India）
  • i2a SA（France）
  • Zhuhai DL Biotech Co., Ltd.（China）
  • GeneFluidics, Inc.（US）
  • Creative Diagnostics（US）
简介目录
Product Code: SQMIG35J2067

Global Microbial Identification Market size was valued at USD 4.5 billion in 2022 and is poised to grow from USD 5.06 billion in 2023 to USD 12.89 billion by 2031, growing at a CAGR of 12.40% during the forecast period (2024-2031).

The global microbial identification market is experiencing notable growth due to the rising incidence of infectious diseases and increasing awareness of the critical role microbial identification plays in disease diagnosis and treatment. The demand for rapid and accurate identification methods is growing across various sectors such as healthcare, pharmaceuticals, food and beverage, and environmental monitoring. Technological innovations, including automated systems, molecular diagnostics, and genomics, have significantly enhanced the microbial identification process, enabling faster and more precise results. The market is further driven by the increasing use of microbial identification in research institutions, biotechnology, and pharmaceutical companies. The emergence of new infectious diseases and the growing concern over antimicrobial resistance have underscored the need for effective identification methods, leading to increased investment in this field. Additionally, the focus on personalized medicine and the demand for point-of-care testing are contributing to the market's expansion. However, high costs associated with advanced identification technologies and a shortage of skilled professionals present challenges to growth. Despite these hurdles, ongoing research and development efforts are expected to drive the global microbial identification market forward, creating opportunities for innovation and enhancing patient care worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microbial Identification market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microbial Identification Market Segmental Analysis

Global Microbial Identification Market is segmented by Product & Service, Method, Technology, Application, End User, and region. Based on Product & Service, the market is segmented into Instruments & Software, Consumables, and Services. Based on Method, the market is segmented into Phenotypic Methods, Proteomics-Based Methods, and Genotypic Methods. Based on Technology, the market is segmented into Mass Spectrometry-Based Microbial Identification Market, PCR Based Microbial Identification Market, Flow Cytometry Based Microbial Identification Market, Microscopy Based Microbial Identification Market, and Other Microbial Identification Technologies. Based on Application, the market is segmented into Diagnostic Applications Pharmaceutical Applications, Food Testing, Beverage Testing, Cosmetics and Personal Care Products Testing, Environmental Applications, and Other Applications. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories, and Blood Banks, Pharmaceutical Companies & Contract Research Organizations, Food Manufacturing Companies, Beverage Manufacturing Companies, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Microbial Identification Market

A major factor driving the growth of the global microbial identification market is the rising prevalence of infectious diseases. The increasing number of infections worldwide has created a strong demand for precise and rapid microbial identification methods, essential for timely diagnosis and effective treatment. This growing need is further amplified by factors like population growth, globalization, and the emergence of new drug-resistant pathogens. These trends emphasize the critical role of reliable microbial identification in healthcare environments, as it aids in combating the spread of infections and ensuring appropriate medical interventions.

Restraints in the Global Microbial Identification Market

A significant restraint in the global microbial identification market is the high cost of advanced identification techniques. Although technological advancements have enhanced the precision and speed of microbial identification, these improvements often come with a hefty price. The expense of acquiring and maintaining advanced equipment, along with the costs of staff training and necessary consumables, can be a financial burden for many. This high cost presents particular challenges for smaller healthcare facilities and regions with limited resources, restricting their ability to adopt these advanced methods. As a result, the widespread implementation of cutting-edge microbial identification techniques is limited, which can slow down market growth to some extent.

Market Trends of the Global Microbial Identification Market

A notable trend in the microbial identification market is the growing adoption of automation and advanced technologies. Laboratories and healthcare facilities are increasingly utilizing automated systems, along with innovative tools such as molecular diagnostics, genomics, and artificial intelligence (AI), to improve the efficiency, precision, and speed of microbial identification. Automation helps streamline processes, minimizes human error, and supports high-throughput testing, resulting in faster and more accurate results. The integration of these advanced technologies provides researchers and clinicians with deeper insights, enabling them to make well-informed decisions and ultimately improve patient care. This trend is largely driven by the rising need for rapid, accurate identification methods, particularly in response to emerging infectious diseases, antimicrobial resistance, and the growing emphasis on personalized medicine.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • Supply chain Analysis
  • Case study Analysis
  • Regulatory Landscape
  • Innovation Matrix
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Microbial Identification Market by Product & Service

  • Market Overview
  • Instruments & Software
  • Consumables
    • Panels/Id Cards & Media
    • Kits
    • Other Consumables
  • Services

Microbial Identification Market by Method

  • Market Overview
  • Phenotypic Methods
  • Proteomics-Based Methods
  • Genotypic Methods

Microbial Identification Market by Technology

  • Market Overview
  • Mass Spectrometry-Based Microbial Identification Market
  • Pcr Based Microbial Identification Market
  • Flow Cytometry Based Microbial Identification Market
  • Microscopy Based Microbial Identification Market
  • Other Microbial Identification Technologies

Microbial Identification Market by Application

  • Market Overview
  • Diagnostic Applications
    • Human Disease Diagnosis
    • Animal Disease Diagnosis
  • Pharmaceutical Applications
  • Food Testing
  • Beverage Testing
  • Cosmetics And Personal Care Products Testing
  • Environmental Applications
  • Other Applications

Microbial Identification Market, By End User

  • Hospitals, Diagnostic Laboratories, and Blood Banks
  • Pharmaceutical Companies & Contract Research Organizations
  • Food Manufacturing Companies
  • Beverage Manufacturing Companies
  • Other End Users

Microbial Identification Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • bioMerieux SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (BD) (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shimadzu Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qiagen NV (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Avantor, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Accelerate Diagnostics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biolog, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Liofilchem S.r.l. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Trivitron Healthcare (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gradian Diagnostics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alifax S.r.l. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HiMedia Laboratories (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • i2a SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zhuhai DL Biotech Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GeneFluidics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Creative Diagnostics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments